These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 10331000
1. Immunization with Escherichia coli-produced soluble MHC class I proteins induces accelerated rejection or prolonged survival of rat cardiac allografts. Perez J, Yu J, Stepkowski SM, Kahan BD. Transplant Proc; 1999 May; 31(3):1560. PubMed ID: 10331000 [No Abstract] [Full Text] [Related]
2. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition. Terness P, Dufter C, Otto G, Opelz G. Transpl Int; 1996 May; 9(1):2-8. PubMed ID: 8748404 [Abstract] [Full Text] [Related]
3. Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts. Fändrich F, Dresske B, Lin X, Huang DS, Zavazava N, Henne-Bruns D. Transplant Proc; 1999 May; 31(3):1558-9. PubMed ID: 10330999 [No Abstract] [Full Text] [Related]
4. Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen. Wang M, Yu J, Stepkowski SM, Kahan BD. Transplant Proc; 1999 May; 31(3):1517-8. PubMed ID: 10330987 [No Abstract] [Full Text] [Related]
5. Induction of tolerance by oral administration of a tolerogenic allochimeric donor/recipient class I MHC protein. Stepkowski SM, Yu J, Wang M, Kahan BD. Transplant Proc; 1999 May; 31(3):1557. PubMed ID: 10330998 [No Abstract] [Full Text] [Related]
6. Induction of donor-specific tolerance by chimeric class I MHC molecules bearing donor alpha 1 helical amino acids. Wang M, Yu J, Wang ME, Tian L, Stepkowski SM, Kahan BD. Transplant Proc; 1997 May; 29(1-2):1224-5. PubMed ID: 9123284 [No Abstract] [Full Text] [Related]
7. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules. Ghobrial RR, Hamashima T, Wang ME, Wang M, Stepkowski SM, Kahan BD. Transplantation; 1996 Oct 15; 62(7):1002-10. PubMed ID: 8878396 [Abstract] [Full Text] [Related]
8. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells. Matsuura T, Hara Y, Imanishi M, Kanda H, Kurita T. Transplant Proc; 1993 Dec 15; 25(6):3283-5. PubMed ID: 8266544 [No Abstract] [Full Text] [Related]
9. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Oluwole SF, Jin MX, Chowdhury NC, Ohajekwe OA. Transplantation; 1994 Nov 27; 58(10):1077-81. PubMed ID: 7974714 [Abstract] [Full Text] [Related]
10. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system. Wang M, Stepkowski SM, Wang ME, Tian L, Qu X, Tu Y, He G, Kahan BD. Transplantation; 1996 Feb 15; 61(3):448-57. PubMed ID: 8610360 [Abstract] [Full Text] [Related]
11. Heart allograft survival in rats following immunization with soluble peptide MHC class I donor antigens: evidence for the role of indirect recognition in rejection. Terness P, Dufter C, Post S, Thies J, Otto G, Koru T, Opelz G. Transpl Int; 1994 Feb 15; 7 Suppl 1():S584-5. PubMed ID: 11271314 [Abstract] [Full Text] [Related]
12. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat. de Bruin RW, van Rossum TJ, Scheringa M, Bonthuis F, IJzermans JN, Marquet RL. Transplantation; 1995 Nov 15; 60(9):1061-3. PubMed ID: 7491686 [No Abstract] [Full Text] [Related]
13. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Transplantation; 1993 May 15; 55(5):1112-8. PubMed ID: 8497891 [Abstract] [Full Text] [Related]
14. Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients. Tange S, Graeb C, Scherer MN, Frank E, Jauch K, Geissler EK. Transplant Proc; 2001 May 15; 33(1-2):579-80. PubMed ID: 11266966 [No Abstract] [Full Text] [Related]
16. Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. Stadlbauer TH, Onodera K, Schaub M, Korom S, Binder J, Sayegh MH, Kupiec-Weglinski JW. Transplant Proc; 1997 May 15; 29(1-2):1016. PubMed ID: 9123176 [No Abstract] [Full Text] [Related]
17. Induction of antigen-specific tolerance: antigen form and injection route. Yoshimura N, Hamashima T, Oka T. Transplant Proc; 1996 Jun 15; 28(3):1150-1. PubMed ID: 8658604 [No Abstract] [Full Text] [Related]
18. Modulation of alloimmunity with class I MHC peptides: mechanisms of action. Mhoyan A, Wu GD, Que X, Cramer DV, Shirwan H. Transplant Proc; 1999 Jun 15; 31(1-2):1189-91. PubMed ID: 10083530 [No Abstract] [Full Text] [Related]
19. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Oluwole SF, Chowdhury NC, Jin MX, Hardy MA. Transplantation; 1993 Dec 15; 56(6):1523-7. PubMed ID: 8279028 [Abstract] [Full Text] [Related]
20. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats. Scherer MN, Graeb C, Tange S, Dyson C, Jauch KW, Geissler EK. Hepatology; 2000 Nov 15; 32(5):999-1007. PubMed ID: 11050050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]